Status and indications for SLIT in comparison to SCIT;Stellenwert und indikation der SLIT im vergleich zur SCIT

Hautarzt

Volumn 59, Issue 7, 2008, Pages 537-543

  Wedi, B ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Major allergen content; SCIT; SLIT; Specific immunotherapy; Uses

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT;

ASTHMA; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFICACY; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; IMMUNOTHERAPY; MEDICAL SOCIETY; PATIENT COMPLIANCE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINOCONJUNCTIVITIS; RISK ASSESSMENT; SKIN SENSITIZATION; TREATMENT INDICATION;

DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 46649093336     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-008-1491-5     Document Type: Review

References (30)

1. Alvarez-Cuesta E, Bousquet J, Canonica GW et al. (2006) Standards for practical allergen-specific immunotherapy. Allergy (Suppl 82) 61: 1-20
2. Bellinghausen I, Allam JP, Bieber T et al. (2007) Wirkmechanismen der spezifischen Immuntherapie. Allergo J 16: 566-569
3. Bohle B, Kinaciyan T, Gerstmayr M et al. (2007) Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 120: 707-713
4. Bousquet J, Khaltaev N, Cruz AA et al. (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (Suppl 86) 63: 8-160
5. Bussmann C, Bockenhoff A, Henke H et al. (2006) Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 118: 1292-1298
6. Calderon MA, Alves B, Jacobson M et al. (2007) Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 1: CD001936
7. Des RA, Paradis L, Menardo JL et al. (1997) Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99: 450-453
8. Di Rienzo V, Marcucci F, Puccinelli P et al. (2003) Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 33: 206-210
9. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP (2006) Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 61: 198-201
10. Inal A, Altintas D, Yilmaz M et al. (2007) Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol 17: 85-91
11. Jacobsen L, Niggemann B, Dreborg S et al. (2007) Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62: 943-948
12. Jacobsen L, Valovirta E (2007) How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma? Curr Opin Allergy Clin Immunol 7: 556-560
13. Johnstone DE, Dutton A (1968) The value of hyposensitization therapy for bronchial asthma in children - a 14-year study. Pediatrics 42: 793-802
14. Kleine-Tebbe J, Bachert C, Bergmann KC et al. (2007) Aktueller Stellenwert der sublingualen Immuntherapie bei allergischen Krankheiten. Allergologie 10: 378-388
15. Kleine-Tebbe J, Bachert C, Bergmann KC et al. (2007) Aktueller Stellenwert der sublingualen Immuntherapie bei allergischen Krankheiten. Allergo J 16: 492-500
16. Kleine-Tebbe J, Bergmann KC, Friedrichs F et al. (2006) Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J 15: 56-74
17. Kleine-Tebbe J, Fuchs T, Klimek L et al. (2000) Die spezifische Immuntherapie (Hyposensibilisierung) mit Allergenen. Allergo J 9: 317-324
18. Kopp MV, Heinzmann A (2007) Applikationsformen der spezifischen Immuntherapie. Allergo J 16: 570-575
19. Lee H-H, Rasche C, Worm M (2007) Sicherheit der spezifischen Immuntherapie. Allergo J 16: 582-585
20. Marogna M, Spadolini I, Massolo A et al. (2004) Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 59: 1205-1210
21. Mösges R, Köberlein J, Schog S (2007) Was kostet die Hyposensibilisierung? Allergo J 16: 586-590
22. Novembre E, Galli E, Landi F et al. (2004) Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 114: 851-857
23. Pajno GB, Barberio G, De LF et al. (2001) Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 31: 1392-1397
24. Pajno GB, Caminiti L, Vita D et al. (2007) Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 120: 164-170
25. Pfaar O, Klimek L (2007) Klinische Erfolgsparameter bei der spezifischen Immuntherapie. Allergo J 16: 576-581
26. Purello-D'Ambrosio F, Gangemi S, Merendino RA et al. (2001) Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 31: 1295-1302
27. Reha CM, Ebru A (2007) Specific immunotherapy is effective in the prevention of new sensitivities. Allergol Immunopathol (Madr) 35: 44-51
28. Schlaud M, Atzpodien K, Thierfelder W (2007) Allergic diseases. Results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50: 701-710
29. Werfel T, Breuer K, Rueff F et al. (2006) Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 61: 202-205
30. Wilson DR, Torres LI, Durham SR (2003) Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev: CD002893